Open session of the standing technical committee of the EUFMD- 2004

Page 241

Appendix 37 Quantification of experimental transmission of FMDV O Taiwan in pigs P.L. Eblé1*, A.A. de Koeijer2, A. Dekker1 : Central Institute of Animal Disease Control (CIDC-Lelystad), P.O. Box 2004, 8203 AA Lelystad, The Netherlands 2 : Department Quantitative Veterinary Epidemiology, Division of Infectious Diseases, Animal Sciences Group Wageningen UR, P.O. Box 65, 8200 AB Lelystad, The Netherlands 1

Introduction To quantify reduction of virus transmission, transmission experiments in which an SIR model is used to estimate reproduction ratio R with a final size method, have shown to be very suitable [1,2]. R is the average number of secondary cases per infectious individual during its entire infectious period [3]. This implies that an infection will fade out in a population when R < 1, but can spread on a large scale when R > 1. Besides R also the transmission rate β is an important parameter, because it can be used in models to optimise control strategies. A GLM method [4] in which information on the time span of the infectious process is used, allows for an accurate calculation of β. Moreover, point estimates of R can be made, using the results of β and the infectious period T [5]. In this study, we quantified the reproduction ratio R and transmission rate β of FMDV after several vaccination strategies. Materials and Methods We performed ten transmission experiments with groups of ten pigs. In each group, five randomly selected pigs were challenged by intra-dermal inoculation in the bulb of the heel of the left hind-foot with 0.1 ml of challenge virus containing 105 TCID50/ml FMDV O Taiwan. The remaining 5 pigs of a group were contact exposed. Four of the groups were non-vaccinated, two groups were vaccinated at 7 days before inoculation (7dpi), one group was vaccinated with a 4-fold vaccine dose (4-FD) at –7dpi, two groups were vaccinated at –14dpi and one group was vaccinated with an (intra-type) heterologous vaccine at – 14dpi. For vaccination we used a commercially available double-oil-in-water emulsion [DOE] containing 3µg of FMDV O Taiwan or O Manisa (heterologous vaccine) 146S antigen per 2 ml dose. Contact infections were determined by inspection of clinical signs, by virus isolation of oropharyngeal fluid (OPF) and plasma samples, (boost of) neutralising antibody titre (VN-titre) and response in an NSP-ELISA. OPF was collected daily after challenge, heparinised blood samples and serum samples were collected at days -14, -11, -7, -4, 0, 3, 7, 10 and 14 dpi. OPF samples and plasma samples were assayed for the presence of virus by plaque titration on monolayers of secondary pig-kidney cells [6]. VN-titres to FMDV O Taiwan and VN-titres to FMDV O Manisa in serum samples were measured using a neutralisation assay [6]. Serum samples were also tested in a commercially available ELISA (UBI® FMDV NS EIA Swine) for detection of antibodies against non-structural proteins of FMDV (NSP-ELISA). Contact pigs were considered infected if FMDV was isolated in OPF or plasma samples or a statistically significant rise in VN-titre was detected or a response in the NSP-ELISA was detected. In the final size method, the estimation of R was based on the final size of the outbreak observed in the experiments. For calculation of R, a stochastic susceptible-infectious-removed (SIR) model was used [7] in which R was calculated using a maximum likelihood estimator [1,8]. For the calculation of R, all inoculated pigs were considered infectious. To determine whether transmission differed significantly between groups, we tested the null hypothesis that there was no difference in transmission between the non-vaccinated and the vaccinated group. In the GLM method, the information of the VI of OPF was used. Data for similar experiments were pooled and the results per day were entered in a GLM (Generalized Linear Model) analysis to estimate the transmission rate using the methodology of Velthuis et al. [4]. We assumed that animals were infectious only at he days that the VI was positive. If euthanasia was applied, the calculation was adjusted by reducing the total group size with one. In cases where the first contact animal became VI-positive simultaneously with the inoculated animals, we assumed that the inoculated group had become infectious half a day earlier. To quantify the infectious period T we used a survival analyses for censored data, using a twoparameter Weibull distribution. Subsequently, R was calculated with the results of β and T as in Klinkenberg et al. [5]. For all three parameters (β, T and R) differences between the vaccinated and non-vaccinated groups were analysed with a T-test. Results In the four non-vaccinated groups, all contact pigs became infected. In the –7dpi vaccinated groups, also all contact pigs became infected. In the group that was vaccinated with a 4-fold vaccine dose at –7dpi, 3 of the 5 contact pigs became infected. In the –14dpi vaccinated groups, both homologous 232


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Appendix 82

17min
pages 492-500

Appendix 77

22min
pages 468-476

Appendix 78

25min
pages 477-484

Appendix 79

14min
pages 485-489

Appendix 81

1min
page 491

Appendix 80

1min
page 490

Appendix 76

12min
pages 464-467

Appendix 75

1min
page 463

Appendix 64

10min
pages 412-414

Appendix 72

13min
pages 455-460

Appendix 73

1min
page 461

Appendix 65

1min
page 415

Appendix 67

1min
page 424

Appendix 63

34min
pages 401-411

Appendix 62

2min
page 400

Appendix 54

8min
pages 361-363

Appendix 61

15min
pages 394-399

Appendix 55

11min
pages 364-366

Appendix 59

1min
page 385

Appendix 60

20min
pages 386-393

Appendix 56

1min
page 367

Appendix 42

21min
pages 270-276

Appendix 52

10min
pages 350-352

Appendix 50

21min
pages 330-339

Appendix 46

2min
page 307

Appendix 37

7min
pages 241-243

Appendix 38

7min
pages 244-246

Appendix 41

2min
page 269

Appendix 40

15min
pages 255-268

Appendix 36

16min
pages 236-240

Appendix 35

15min
pages 231-235

Appendix 34

25min
pages 224-230

Appendix 28

2min
page 198

Appendix 31

10min
pages 212-215

Appendix 29

16min
pages 199-203

Appendix 33

3min
pages 221-223

Appendix 27

1min
page 197

Appendix 26

27min
pages 188-196

Appendix 25

12min
pages 182-187

Appendix 23

8min
pages 168-171

Appendix 22

28min
pages 158-167

Appendix 15

2min
page 113

Appendix 16

7min
pages 114-116

Appendix 20 EMEA paper extract - Recommendations for tests for induction of antibodies to NSP antigens by FMD vaccines

4min
pages 144-145

Appendix 19

18min
pages 136-143

Appendix 14

4min
page 112

Appendix 13

10min
pages 107-111

Appendix 5

2min
page 64

Appendix 12

9min
pages 104-106

Appendix 3

9min
pages 47-49

Appendix 4

26min
pages 50-63

Appendix 8

12min
pages 77-80

Appendix 2

8min
pages 43-46

Open Session

6min
pages 39-42

Closed Session

2min
pages 37-38

Item 11 – Persistent and subclinical infections – diagnostic and surveillance issues

3min
page 33

Item 15 – Managing the decision-making process in control of FMD and in the priority setting of research and development

3min
page 36

Item 14 – Regulatory compliance

2min
page 35

Item 10 – International issues

3min
page 32

Item 9 – Novel vaccines

3min
page 31

Item 7 – Optimisation of conventional vaccines

3min
page 29

Item 4 – Managing diagnostic demands

3min
page 27

Item 8 – Regulatory issues affecting FMD vacine selection and use

3min
page 30

Item 3 – Transmission and its control

3min
page 26

3.4.2 Post-vaccination serosurveillance (PVS) for presence of FMD infected animals

3min
page 16

Item 1 – Recent findings in molecular epidemiology of FMDV

3min
page 24

Item 2 – Surveillance: for what purpose and how much is enough?

3min
page 25

4.2 Collection of sera/specimens for validation of DIVA tests for detection of animals received from SAT virus infection

3min
page 20
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.